nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—HTR2A—conduct disorder	0.911	1	CbGaD
Molindone—DRD2—Dopamine receptors—DRD4—conduct disorder	0.00695	0.0909	CbGpPWpGaD
Molindone—HTR7—autonomic nervous system—conduct disorder	0.0059	0.463	CbGeAlD
Molindone—HTR2A—autonomic nervous system—conduct disorder	0.00368	0.289	CbGeAlD
Molindone—HTR7—Serotonin receptors—HTR2A—conduct disorder	0.00346	0.0453	CbGpPWpGaD
Molindone—HTR1A—Serotonin receptors—HTR2A—conduct disorder	0.00256	0.0335	CbGpPWpGaD
Molindone—HTR7—Monoamine GPCRs—DRD4—conduct disorder	0.00236	0.0309	CbGpPWpGaD
Molindone—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00221	0.0288	CbGpPWpGaD
Molindone—HTR7—Amine ligand-binding receptors—DRD4—conduct disorder	0.00198	0.026	CbGpPWpGaD
Molindone—HTR1A—Monoamine GPCRs—DRD4—conduct disorder	0.00175	0.0229	CbGpPWpGaD
Molindone—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00157	0.0206	CbGpPWpGaD
Molindone—HTR7—Monoamine GPCRs—HTR2A—conduct disorder	0.00154	0.0201	CbGpPWpGaD
Molindone—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.00154	0.0201	CbGpPWpGaD
Molindone—HTR2A—Monoamine GPCRs—DRD4—conduct disorder	0.00151	0.0198	CbGpPWpGaD
Molindone—CHRM1—Monoamine GPCRs—DRD4—conduct disorder	0.0015	0.0197	CbGpPWpGaD
Molindone—HTR1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00147	0.0192	CbGpPWpGaD
Molindone—HTR7—G alpha (s) signalling events—CGA—conduct disorder	0.00146	0.0191	CbGpPWpGaD
Molindone—ADRA2A—Monoamine GPCRs—DRD4—conduct disorder	0.00138	0.018	CbGpPWpGaD
Molindone—HTR7—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0013	0.0169	CbGpPWpGaD
Molindone—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.00129	0.0169	CbGpPWpGaD
Molindone—HTR2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00127	0.0166	CbGpPWpGaD
Molindone—CHRM1—Amine ligand-binding receptors—DRD4—conduct disorder	0.00126	0.0165	CbGpPWpGaD
Molindone—ADRA2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00116	0.0151	CbGpPWpGaD
Molindone—HTR1A—Monoamine GPCRs—HTR2A—conduct disorder	0.00114	0.0149	CbGpPWpGaD
Molindone—HTR7—GPCRs, Other—DRD4—conduct disorder	0.00105	0.0137	CbGpPWpGaD
Molindone—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.001	0.0131	CbGpPWpGaD
Molindone—CHRM1—Monoamine GPCRs—HTR2A—conduct disorder	0.000981	0.0128	CbGpPWpGaD
Molindone—HTR1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00096	0.0125	CbGpPWpGaD
Molindone—ADRA2A—Monoamine GPCRs—HTR2A—conduct disorder	0.000897	0.0117	CbGpPWpGaD
Molindone—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000843	0.011	CbGpPWpGaD
Molindone—CHRM1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000825	0.0108	CbGpPWpGaD
Molindone—ADRA2A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000754	0.00986	CbGpPWpGaD
Molindone—HTR7—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000697	0.00912	CbGpPWpGaD
Molindone—HTR7—GPCRs, Other—HTR2A—conduct disorder	0.000684	0.00895	CbGpPWpGaD
Molindone—HTR2A—GPCRs, Other—DRD4—conduct disorder	0.000671	0.00878	CbGpPWpGaD
Molindone—CHRM1—brain—conduct disorder	0.00067	0.0526	CbGeAlD
Molindone—CHRM1—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.000644	0.00842	CbGpPWpGaD
Molindone—HTR1A—brain—conduct disorder	0.000597	0.0469	CbGeAlD
Molindone—HTR7—Circadian rythm related genes—SLC6A4—conduct disorder	0.000592	0.00774	CbGpPWpGaD
Molindone—HTR7—brain—conduct disorder	0.000571	0.0448	CbGeAlD
Molindone—HTR7—Circadian rythm related genes—DRD4—conduct disorder	0.000556	0.00728	CbGpPWpGaD
Molindone—DRD2—brain—conduct disorder	0.00054	0.0424	CbGeAlD
Molindone—HTR1A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000537	0.00702	CbGpPWpGaD
Molindone—HTR7—GPCR ligand binding—CGA—conduct disorder	0.000531	0.00694	CbGpPWpGaD
Molindone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000517	0.00676	CbGpPWpGaD
Molindone—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000464	0.00607	CbGpPWpGaD
Molindone—HTR7—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000456	0.00596	CbGpPWpGaD
Molindone—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000454	0.00593	CbGpPWpGaD
Molindone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000446	0.00584	CbGpPWpGaD
Molindone—CHRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000444	0.00581	CbGpPWpGaD
Molindone—ADRA2A—brain—conduct disorder	0.000419	0.0329	CbGeAlD
Molindone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000406	0.00531	CbGpPWpGaD
Molindone—HTR1A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000404	0.00529	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—CGA—conduct disorder	0.000393	0.00514	CbGpPWpGaD
Molindone—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00039	0.00511	CbGpPWpGaD
Molindone—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000385	0.00504	CbGpPWpGaD
Molindone—CHRM1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000377	0.00493	CbGpPWpGaD
Molindone—HTR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.000364	0.00476	CbGpPWpGaD
Molindone—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000362	0.00473	CbGpPWpGaD
Molindone—HTR2A—brain—conduct disorder	0.000356	0.0279	CbGeAlD
Molindone—CHRM1—Circadian rythm related genes—DRD4—conduct disorder	0.000354	0.00463	CbGpPWpGaD
Molindone—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000349	0.00457	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000345	0.00452	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.00034	0.00444	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—CGA—conduct disorder	0.000338	0.00442	CbGpPWpGaD
Molindone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000338	0.00442	CbGpPWpGaD
Molindone—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000329	0.00431	CbGpPWpGaD
Molindone—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000319	0.00418	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.000309	0.00404	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—CGA—conduct disorder	0.0003	0.00392	CbGpPWpGaD
Molindone—HTR7—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000297	0.00389	CbGpPWpGaD
Molindone—HTR7—GPCR ligand binding—DRD4—conduct disorder	0.000297	0.00389	CbGpPWpGaD
Molindone—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000296	0.00388	CbGpPWpGaD
Molindone—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000292	0.00381	CbGpPWpGaD
Molindone—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00029	0.00379	CbGpPWpGaD
Molindone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000289	0.00378	CbGpPWpGaD
Molindone—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.000286	0.00374	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—CGA—conduct disorder	0.000272	0.00356	CbGpPWpGaD
Molindone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000265	0.00347	CbGpPWpGaD
Molindone—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000255	0.00333	CbGpPWpGaD
Molindone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000254	0.00332	CbGpPWpGaD
Molindone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00025	0.00327	CbGpPWpGaD
Molindone—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000249	0.00325	CbGpPWpGaD
Molindone—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000245	0.0032	CbGpPWpGaD
Molindone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000227	0.00297	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000222	0.00291	CbGpPWpGaD
Molindone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00022	0.00288	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.00022	0.00288	CbGpPWpGaD
Molindone—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000219	0.00286	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000202	0.00264	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000195	0.00255	CbGpPWpGaD
Molindone—HTR7—GPCR ligand binding—HTR2A—conduct disorder	0.000194	0.00254	CbGpPWpGaD
Molindone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000193	0.00253	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000193	0.00253	CbGpPWpGaD
Molindone—HTR7—Circadian rythm related genes—EP300—conduct disorder	0.000192	0.00252	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000192	0.00251	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.000191	0.0025	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.00019	0.00249	CbGpPWpGaD
Molindone—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000189	0.00248	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.000189	0.00248	CbGpPWpGaD
Molindone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000189	0.00247	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000177	0.00232	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.000175	0.00229	CbGpPWpGaD
Molindone—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000175	0.00228	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.000174	0.00228	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—CGA—conduct disorder	0.000173	0.00227	CbGpPWpGaD
Molindone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000173	0.00226	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.000173	0.00226	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—DRD4—conduct disorder	0.000168	0.0022	CbGpPWpGaD
Molindone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000166	0.00217	CbGpPWpGaD
Molindone—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000162	0.00212	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CGA—conduct disorder	0.000161	0.0021	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.000159	0.00208	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—DRD4—conduct disorder	0.000153	0.002	CbGpPWpGaD
Molindone—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000151	0.00197	CbGpPWpGaD
Molindone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000148	0.00194	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	0.000144	0.00188	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—WASF1—conduct disorder	0.000129	0.00169	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000126	0.00165	CbGpPWpGaD
Molindone—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.000125	0.00164	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	0.000125	0.00163	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	0.000124	0.00162	CbGpPWpGaD
Molindone—CHRM1—Circadian rythm related genes—EP300—conduct disorder	0.000122	0.0016	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CGA—conduct disorder	0.000119	0.00156	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—DRD4—conduct disorder	0.000113	0.00148	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	0.000113	0.00148	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—CGA—conduct disorder	0.000112	0.00147	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	0.00011	0.00143	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.000109	0.00143	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	0.000108	0.00141	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	0.000107	0.0014	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CGA—conduct disorder	0.000105	0.00137	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CGA—conduct disorder	0.000103	0.00135	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CGA—conduct disorder	0.000102	0.00134	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—HTR2A—conduct disorder	9.95e-05	0.0013	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—DRD4—conduct disorder	9.93e-05	0.0013	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	9.79e-05	0.00128	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—DRD4—conduct disorder	9.77e-05	0.00128	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—DRD4—conduct disorder	9.71e-05	0.00127	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—WASF1—conduct disorder	9.56e-05	0.00125	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CGA—conduct disorder	9.37e-05	0.00123	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—DRD4—conduct disorder	9.01e-05	0.00118	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	8.89e-05	0.00116	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—WASF1—conduct disorder	8.39e-05	0.0011	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—WASF1—conduct disorder	8.26e-05	0.00108	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—WASF1—conduct disorder	8.21e-05	0.00107	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	8.12e-05	0.00106	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—WASF1—conduct disorder	7.51e-05	0.000982	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	7.38e-05	0.000965	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	7.13e-05	0.000933	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	6.98e-05	0.000913	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—DRD4—conduct disorder	6.68e-05	0.000873	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—HTR2A—conduct disorder	6.48e-05	0.000847	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	6.38e-05	0.000835	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	6.34e-05	0.000829	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—HTR2A—conduct disorder	5.88e-05	0.000769	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—DRD4—conduct disorder	5.86e-05	0.000767	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	5.8e-05	0.000758	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—DRD4—conduct disorder	5.77e-05	0.000755	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—DRD4—conduct disorder	5.74e-05	0.000751	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—EP300—conduct disorder	5.35e-05	0.0007	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—DRD4—conduct disorder	5.25e-05	0.000686	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—COMT—conduct disorder	5.06e-05	0.000662	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—MAOA—conduct disorder	5.02e-05	0.000657	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—HTR2A—conduct disorder	4.36e-05	0.00057	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—HTR2A—conduct disorder	3.83e-05	0.0005	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—HTR2A—conduct disorder	3.74e-05	0.00049	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	3.42e-05	0.000448	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—EP300—conduct disorder	3.12e-05	0.000407	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—EP300—conduct disorder	2.31e-05	0.000302	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—EP300—conduct disorder	2.17e-05	0.000284	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—EP300—conduct disorder	2.03e-05	0.000265	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—EP300—conduct disorder	1.99e-05	0.000261	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EP300—conduct disorder	1.98e-05	0.000259	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EP300—conduct disorder	1.81e-05	0.000237	CbGpPWpGaD
